Suppr超能文献

OPTN/SRTR 2022 年度数据报告:心脏

OPTN/SRTR 2022 Annual Data Report: Heart.

机构信息

Scientific Registry of Transplant Recipients, Hennepin Healthcare Research Institute, Minneapolis, MN; Department of Cardiology, University of Michigan, Ann Arbor, MI.

Scientific Registry of Transplant Recipients, Hennepin Healthcare Research Institute, Minneapolis, MN; Department of Pediatrics, University of Washington, Seattle, WA.

出版信息

Am J Transplant. 2024 Feb;24(2S1):S305-S393. doi: 10.1016/j.ajt.2024.01.016.

Abstract

The number of heart transplants in the United States has continued to increase. Since 2011, pediatric heart transplants have increased 31.7% to 494 and adult heart transplants have increased 85.8% to 3,668 in 2022. The numbers of new candidates for pediatric and adult heart transplants have also increased, with 703 new pediatric candidates and 4,446 new adult candidates in 2022. Adult heart transplant rates continue to rise, peaking at 122.5 transplants per 100 patient-years in 2022; however, the pediatric heart transplant rate decreased to its lowest rate in the past decade, 104.2 transplants per 100 patient-years, a decrease of 13.9% from 121 transplants per 100 patient-years in 2011. Despite this, pretransplant mortality among pediatric candidates has decreased by 52.2%, from 20.8 deaths per 100 patient-years in 2011 to 10.0 deaths per 100 patient-years in 2022, but remains excessive for candidates younger than 1 year at 25.7 deaths per 100 patient-years. Among adult candidates, pretransplant mortality declined from 15 deaths per 100 patient-years in 2011 to 8.7 deaths per 100 patient-years in 2022. Since 2011, posttransplant mortality has been stable to slightly better; among recipients who underwent transplant in 2015-2017, the 1-, 3-, and 5-year pediatric survival rates were 93.7%, 89.2%, and 85.0%, respectively, and the adult survival rates were 91.3%, 85.7%, and 80.4%. Donor trends have been favorable, with an increase in the numbers of hearts recovered and growing numbers of hearts procured after circulatory death.

摘要

美国的心脏移植数量持续增加。自 2011 年以来,儿科心脏移植数量增加了 31.7%,达到 494 例,成人心脏移植数量增加了 85.8%,达到 2022 年的 3668 例。儿科和成人心脏移植的新候选人数也有所增加,2022 年有 703 名新的儿科候选人和 4446 名新的成人候选。成人心脏移植率继续上升,2022 年达到每 100 个患者年 122.5 次移植的峰值;然而,儿科心脏移植率降至过去十年的最低水平,每 100 个患者年 104.2 次移植,比 2011 年每 100 个患者年 121 次移植下降了 13.9%。尽管如此,儿科候选者的移植前死亡率下降了 52.2%,从 2011 年的每 100 个患者年 20.8 例死亡降至 2022 年的每 100 个患者年 10.0 例死亡,但对于 1 岁以下的候选者仍然过高,为每 100 个患者年 25.7 例死亡。在成年候选者中,移植前死亡率从 2011 年的每 100 个患者年 15 例死亡下降到 2022 年的每 100 个患者年 8.7 例死亡。自 2011 年以来,移植后的死亡率一直稳定或略有改善;在 2015-2017 年接受移植的受者中,1 年、3 年和 5 年的儿科生存率分别为 93.7%、89.2%和 85.0%,成年生存率分别为 91.3%、85.7%和 80.4%。供体趋势良好,回收的心脏数量增加,循环死亡后获取的心脏数量也在增加。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验